Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 42
Filter
Add more filters










Publication year range
1.
Health Psychol ; 43(7): 539-549, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38573690

ABSTRACT

OBJECTIVE: People likely have different attitudes toward different vaccines (e.g., they may hold a positive attitude toward the measles, mumps, and rubella-vaccine while simultaneously hold a neutral attitude toward the flu shot). To examine the dimensionality of vaccination intentions, we measured vaccination intentions toward 16 different diseases. We hypothesized that people differentiate between child-directed vaccination intentions and self-directed vaccination intentions. Furthermore, we hypothesized that some commonly studied factors (e.g., trust in authorities and fear of needles) might have different associations with the two subtypes of vaccination intentions. METHOD: We used data from a nationally representative sample of the Netherlands collected in 2021. We used exploratory (N = 865) and confirmatory factor analysis (N = 865) to evaluate the dimensionality hypothesis and used linear hypothesis tests (N = 1,779) to test whether the commonly studied factors had different associations with the different subtypes of vaccination intentions. RESULTS: The analysis showed two distinct factors of vaccination intentions: intentions toward childhood diseases and intentions toward nonchildhood diseases. Additionally, spiritual beliefs, trust in authorities, and belief in conspiracy theories had stronger associations with nonchildhood diseases than with childhood diseases. Fear of needles, prosocial personality, and religious orthodox beliefs did not have different associations with both types of vaccination intentions. CONCLUSIONS: These findings suggest that vaccination intentions is a multidimensional construct and that interventions may benefit from being tailored to the factors relevant for each specific type of vaccine. (PsycInfo Database Record (c) 2024 APA, all rights reserved).


Subject(s)
Intention , Vaccination , Humans , Male , Female , Adult , Vaccination/psychology , Netherlands , Middle Aged , Adolescent , Young Adult , Health Knowledge, Attitudes, Practice , Surveys and Questionnaires , Trust , Aged
2.
Clin Toxicol (Phila) ; 52(6): 611-7, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24844579

ABSTRACT

CONTEXT: Nitromethane interferes with Jaffé measurements of creatinine, potentially mimicking acute kidney injury. OBJECTIVES: We determined the proportional contribution of nitromethane in blood samples to creatinine measured by the Jaffé colorimetric and the point-of-care (POC) reactions and determined whether the difference can reliably estimate the concentration of nitromethane. Additionally, we determined whether the presence of nitromethane interferes with anion/osmolal gaps and ascertained the stability of nitromethane in serum after 7 days. METHODS: Nitromethane was added to whole blood from four healthy volunteers to achieve concentrations of 0, 0.25, 0.5, 1, and 2 mmol/L. The following tests were performed: creatinine (Jaffé and POC), electrolytes (associated with Jaffé and POC), osmolality and nitromethane concentration (gas chromatography [GC]). Remaining samples were refrigerated and reanalyzed using GC at 7 days. Anion and osmolal gaps were calculated. Proportional recovery and degradation of nitromethane were measured using GC. Data were analyzed for agreement with single-factor ANOVA (p = 0.05). RESULTS: Mean creatinine for POC and Jaff methods were 0.93 vs. 0.76 mg/dL, respectively. Jaff creatinine concentrations increased linearly with increasing nitromethane concentrations (R(2) = 1, p = 0.01): measured creatinine (mg/dL) = 7.1*nitromethane (mmol/L) = 0.79. POC creatinine remained unchanged across the range of nitromethane concentrations (p = 0.99). Anion and osmolal gaps also remained unchanged. Nitromethane was reliably identified in all sample concentrations using GC on Day 0. Detection of 0.25 mmol/L nitromethane was not consistently recovered on Day 7. Nitromethane degradation was most pronounced at 2 mmol/L concentrations (81% recovery). CONCLUSIONS: Nitromethane alters apparent concentration of creatinine using the Jaffé reaction in a linear fashion but not when using the POC reaction. Measured difference between Jaffé and POC creatinine may identify the presence and estimate concentration of nitromethane. Presence of nitromethane did not alter the anion or osmolal gap; thus it would not potentially interfere with the diagnosis of co-exposure to a toxic alcohol.


Subject(s)
Acid-Base Equilibrium , Creatinine/blood , Methane/analogs & derivatives , Nitroparaffins/blood , Osmolar Concentration , Point-of-Care Systems , Acid-Base Equilibrium/drug effects , Adolescent , Adult , Chromatography, Gas , Colorimetry , Female , Humans , Male , Methane/blood , Methane/pharmacokinetics , Methane/pharmacology , Nitroparaffins/pharmacokinetics , Nitroparaffins/pharmacology , Young Adult
3.
J Bacteriol ; 195(2): 389-98, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23161027

ABSTRACT

The Sinorhizobium meliloti BacA ABC transporter protein plays an important role in its nodulating symbiosis with the legume alfalfa (Medicago sativa). The Mycobacterium tuberculosis BacA homolog was found to be important for the maintenance of chronic murine infections, yet its in vivo function is unknown. In the legume plant as well as in the mammalian host, bacteria encounter host antimicrobial peptides (AMPs). We found that the M. tuberculosis BacA protein was able to partially complement the symbiotic defect of an S. meliloti BacA-deficient mutant on alfalfa plants and to protect this mutant in vitro from the antimicrobial activity of a synthetic legume peptide, NCR247, and a recombinant human ß-defensin 2 (HBD2). This finding was also confirmed using an M. tuberculosis insertion mutant. Furthermore, M. tuberculosis BacA-mediated protection of the legume symbiont S. meliloti against legume defensins as well as HBD2 is dependent on its attached ATPase domain. In addition, we show that M. tuberculosis BacA mediates peptide uptake of the truncated bovine AMP, Bac7(1-16). This process required a functional ATPase domain. We therefore suggest that M. tuberculosis BacA is important for the transport of peptides across the cytoplasmic membrane and is part of a complete ABC transporter. Hence, BacA-mediated protection against host AMPs might be important for the maintenance of latent infections.


Subject(s)
Bacterial Proteins/metabolism , Genetic Complementation Test , Membrane Transport Proteins/deficiency , Membrane Transport Proteins/metabolism , Mycobacterium tuberculosis/genetics , Sinorhizobium meliloti/physiology , Symbiosis , Anti-Infective Agents/pharmacology , Bacterial Proteins/genetics , Medicago sativa/microbiology , Medicago sativa/physiology , Membrane Transport Proteins/genetics , Sinorhizobium meliloti/drug effects , Sinorhizobium meliloti/genetics , beta-Defensins/pharmacology
4.
Clin Microbiol Infect ; 16(5): 411-8, 2010 May.
Article in English | MEDLINE | ID: mdl-20132250

ABSTRACT

Streptococcus pneumoniae is a major pathogen of humans, causing diseases such as pneumonia and meningitis. The organism produces several virulence factors that are involved in the disease process. The molecular basis of the action of some of these virulence factors is being elucidated. The advent of whole genome sequencing combined with biological studies has demonstrated that genome variation is important in the ability of pneumococci to interact with the host. This review discusses the biological activity of several pneumococcal virulence factors, and describes how genome variation may impact on the ability of pneumococci to cause disease.


Subject(s)
Pneumococcal Infections/microbiology , Streptococcus pneumoniae/genetics , Streptococcus pneumoniae/pathogenicity , Virulence Factors/genetics , Genetic Variation , Humans
6.
J Thromb Haemost ; 5(1): 50-4, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17026644

ABSTRACT

OBJECTIVE: To estimate the frequency of contrast nephropathy after computed tomography angiography (CTA) to rule out pulmonary embolism (PE) in the emergency department (ED) setting. METHODS: We prospectively followed patients undergoing CTA for PE, while in the ED, for 45 days. Patients who refused follow-up or were receiving hemodialysis were excluded. Severe renal failure was defined as an increase in creatinine > or = 3.0 mg dL(-1) or a need for hemodialysis within the follow-up period. Patients were also followed for laboratory-defined contrast nephropathy, defined as an increase in creatinine of > 0.5 mg dL(-1) or > 25%, within seven days following CTA. RESULTS: A total of 1224 patients were followed, and 354 [29%, 95% confidence interval (CI): 26-32%] patients had paired (preCTA and post-CTA) creatinine measurements. None developed renal failure (0/1224; 0%, CI: 0-0.3%). 44 patients developed laboratory-defined contrast nephropathy, corresponding to an overall frequency of 4% (44/1224; CI: 3-5%) and 12% (44/354; 95% CI: 9-16%) among those with paired creatinine measurements. CONCLUSIONS: Following CTA for PE, the incidence of severe renal failure was very low, but the incidence of laboratory-defined contrast nephropathy (4% overall and 12% of those with paired measurements) was higher than expected.


Subject(s)
Angiography , Contrast Media/adverse effects , Emergency Service, Hospital , Iopamidol/adverse effects , Pulmonary Embolism/diagnostic imaging , Renal Insufficiency/chemically induced , Tomography, X-Ray Computed , Angiography/methods , Coronary Artery Disease/complications , Creatinine/blood , Female , Follow-Up Studies , Humans , Incidence , Kidney Function Tests , Male , Middle Aged , Prospective Studies , Pulmonary Embolism/blood , Renal Insufficiency/blood , Renal Insufficiency/epidemiology , Risk Assessment , Risk Factors , Severity of Illness Index , Time Factors , Tomography, X-Ray Computed/methods , United States
7.
J Endocrinol ; 185(1): 93-8, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15817830

ABSTRACT

Verapamil inhibits tri-iodothyronine (T3) efflux from several cell types, suggesting the involvement of multidrug resistance-associated (MDR) proteins in T3 transport. The direct involvement of P-glycoprotein (P-gp) has not, however, been investigated. We compared the transport of 125I-T3 in MDCKII cells that had been transfected with mdr1 cDNA (MDCKII-MDR) versus wild-type MDCKII cells (MDCKII), and examined the effect of conventional (verapamil and nitrendipine) and specific MDR inhibitors (VX 853 and VX 710) on 125I-T3 efflux. We confirmed by Western blotting the enhanced expression of P-gp in MDCKII-MDR cells. The calculated rate of 125I-T3 efflux from MDCKII-MDR cells (around 0.30/min) was increased twofold compared with MDCKII cells (around 0.15/min). Overall, cellular accumulation of 125I-T3 was reduced by 26% in MDCKII-MDR cells compared with MDCKII cells, probably reflecting enhanced export of T3 from MDCKII-MDR cells rather than reduced cellular uptake, as P-gp typically exports substances from cells. Verapamil lowered the rate of 125I-T3 efflux from both MDCKII and MDCKII-MDR cells by 42% and 66% respectively, while nitrendipine reduced 125I-T3 efflux rate by 36% and 48% respectively, suggesting that both substances inhibited other cellular T3 transporters in addition to P-gp. The specific MDR inhibitors VX 853 and VX 710 had no effect of 125I-T3 efflux rate from wild-type MDCKII cells but reduced 125I-T3 export in MDCKII-MDR cells by 50% and 53% respectively. These results have provided the first direct evidence that P-gp exports thyroid hormone from cells.


Subject(s)
ATP Binding Cassette Transporter, Subfamily B, Member 1/metabolism , ATP Binding Cassette Transporter, Subfamily B/metabolism , Kidney/metabolism , Triiodothyronine/metabolism , ATP Binding Cassette Transporter, Subfamily B/antagonists & inhibitors , ATP Binding Cassette Transporter, Subfamily B, Member 1/genetics , Animals , Biological Transport/drug effects , Blotting, Western/methods , Cell Line , Cell Membrane/metabolism , Dogs , Drug Resistance, Multiple/drug effects , Iodine Radioisotopes , Nitrendipine/pharmacology , Piperidines/pharmacology , Pyridines/pharmacology , Transfection , Verapamil/pharmacology
8.
J Thromb Haemost ; 2(8): 1247-55, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15304025

ABSTRACT

Overuse of the d-dimer to screen for possible pulmonary embolism (PE) can have negative consequences. This study derives and tests clinical criteria to justify not ordering a d-dimer. The test threshold was estimated at 1.8% using the method of Pauker and Kassirer. The PE rule-out criteria were derived from logistic regression analysis with stepwise backward elimination of 21 variables collected on 3148 emergency department patients evaluated for PE at 10 US hospitals. Eight variables were included in a block rule: Age < 50 years, pulse < 100 bpm, SaO(2) > 94%, no unilateral leg swelling, no hemoptysis, no recent trauma or surgery, no prior PE or DVT, no hormone use. The rule was then prospectively tested in a low-risk group (1427 patients from two hospitals initially tested for PE with a d-dimer) and a very low-risk group (convenience sample of 382 patients with chief complaint of dyspnea, PE not suspected). The prevalence of PE was 8% (95% confidence interval: 7-9%) in the low-risk group and 2% (1-4%) in the very low-risk group on longitudinal follow-up. Application of the rule in the low-risk and very low-risk populations yielded sensitivities of 96% and 100% and specificities of 27% and 15%, respectively. The prevalence of PE in those who met the rule criteria was 1.4% (0.5-3.0%) and 0% (0-6.2%), respectively. The derived eight-factor block rule reduced the pretest probability below the test threshold for d-dimer in two validation populations, but the rule's utility was limited by low specificity.


Subject(s)
Emergency Medicine/methods , Fibrin Fibrinogen Degradation Products/biosynthesis , Pulmonary Embolism/blood , Pulmonary Embolism/diagnosis , Adult , Female , Humans , Logistic Models , Male , Middle Aged , Oxygen/metabolism , Prevalence , Research Design , Risk
9.
Can J Anaesth ; 48(9): 850-3, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11606339

ABSTRACT

PURPOSE: To document the preoperative core temperature of adult elective surgical patients. METHODS: A prospective audit obtained sublingual temperatures from 446 adult elective surgical patients on arrival in the preoperative holding area. RESULTS: Temperatures ranged from 35.7 degrees C to 37.8 degrees C with a mean of 36.5 degrees C (0.4 SD). The median was 36.4 degrees C and the mode was 36.1 degrees C. There was a skewed distribution with a clustering of values at the lower end of the range. All recordings were within the accepted normothermic range. CONCLUSION: The asymmetric distribution we observed differs from previously published normothermia data which shows a symmetrical distribution of temperatures. This skewed distribution has not previously been documented and we interpret it as being due to the effect of preoperative cooling factors.


Subject(s)
Body Temperature , Preoperative Care , Adolescent , Adult , Aged , Aged, 80 and over , Elective Surgical Procedures , Female , Humans , Male , Middle Aged , Prospective Studies
10.
Placenta ; 22(2-3): 256-8, 2001.
Article in English | MEDLINE | ID: mdl-11170832

ABSTRACT

The placenta must allow the passage of iodide from the maternal to the fetal circulation for synthesis of thyroxine by the fetal thyroid. The thyroid sodium iodide symporter (NIS) was cloned in 1996 and, although widely distributed among epithelial tissues, early studies failed to detect it in placenta. We demonstrated NIS mRNA in human placenta and in the human choriocarcinoma cell line, JAr. NIS protein was localized to trophoblasts, with a tendency to apical distribution, in sections of human placenta immunostained with a monoclonal antibody against hNIS. We conclude that NIS is expressed in placenta and may mediate placental iodide transport.


Subject(s)
Carrier Proteins/genetics , Gene Expression , Membrane Proteins/genetics , Placenta/chemistry , Symporters , Antibodies, Monoclonal , Carrier Proteins/analysis , Choriocarcinoma/chemistry , Female , Graves Disease/metabolism , Humans , Membrane Proteins/analysis , Pregnancy , RNA, Messenger/analysis , Reverse Transcriptase Polymerase Chain Reaction , Thyroid Gland/chemistry , Tissue Distribution , Trophoblasts/chemistry , Tumor Cells, Cultured , Uterine Neoplasms/chemistry
11.
J Endocrinol ; 167(3): 487-92, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11115776

ABSTRACT

We investigated transport systems for tri-iodothyronine (T(3)) and thyroxine (T(4)) in the human choriocarcinoma cell line, JAR, using a range of structurally similar compounds to determine whether these thyroid hormones are transported by common or different mechanisms. Saturable T(3) but not saturable T(4) uptake was inhibited by a wide range of aromatic compounds (nitrendipine, nifedipine, verapamil, meclofenamic acid, mefenamic acid, diazepam, phenytoin). Nitrendipine and diazepam were the most effective inhibitors of saturable thyroid hormone uptake. Nitrendipine decreased the K(m) for T(4) uptake from a control value of around 500 nM to around 300 nM (n=6). In contrast, the K(m) for T(3) uptake was increased from a control value of around 300 nM to around 750 nM (n=4). Diazepam had similar effects. This divergent shift in affinity for the uptake of T(3) and T(4) suggested that separate uptake systems exist for these two thyroid hormones. This provides evidence for at least two transporters mediating uptake of T(3) and T(4) in JAR cells: a specific T(4) transporter that does not interact with T(3) or structurally similar compounds; and a shared iodothyronine transporter that interacts with T(3), T(4), nitrendipine and diazepam.


Subject(s)
Choriocarcinoma/metabolism , Thyroxine/pharmacokinetics , Triiodothyronine/pharmacokinetics , Uterine Neoplasms/metabolism , Analysis of Variance , Biological Transport/drug effects , Calcium Channel Blockers/pharmacology , Cyclooxygenase Inhibitors/pharmacology , Diazepam/pharmacology , Female , GABA Modulators/pharmacology , Humans , Iodine Radioisotopes , Leucine/pharmacology , Meclofenamic Acid/pharmacology , Mefenamic Acid/pharmacology , Nifedipine/pharmacology , Nitrendipine/pharmacology , Phenylalanine/pharmacology , Phenytoin/pharmacology , Tryptophan/pharmacology , Tumor Cells, Cultured , Verapamil/pharmacology
12.
Placenta ; 21(2-3): 283-5, 2000.
Article in English | MEDLINE | ID: mdl-10736255

ABSTRACT

We examined uptake of l -thyroxine sulphate (T(4)S) and possible interactions between T(4)S and thyroxine (T(4)) uptake in the choriocarcinoma cell line JAr. Cells were incubated with 50 p m(125)I-T(4)S in the absence (total uptake) and in the presence (non-specific uptake) of 10 microm T(4)S. Cells were also incubated at 37 degrees C for 2 min with 50 p m(125)I-T(4)in the presence of an increasing amount of unlabelled T(4)(0-10 microm) or T(4)S (0-30 microm). There was negligible total uptake of(125)I-T(4)S (1.14+/-0. 05 fmol/mg cellular protein, mean+/-sem) and no specific uptake after 120 min incubation. Minor inhibition of(125)I-T(4)uptake by T(4)S could be explained entirely by a low level of residual T(4)(0. 2 per cent) in the T(4)S preparation. These findings indicate that T(4)S does not share the T(4)membrane transporter.


Subject(s)
Choriocarcinoma/metabolism , Thyroxine/analogs & derivatives , Uterine Neoplasms/metabolism , Biological Transport, Active , Cell Membrane/metabolism , Female , Humans , Kinetics , Models, Biological , Placenta/metabolism , Pregnancy , Thyroxine/metabolism , Tumor Cells, Cultured
13.
J Endocrinol ; 161(1): 107-13, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10194534

ABSTRACT

We compared the specificities of transport mechanisms for uptake and efflux of thyroid hormones in cells of the human choriocarcinoma cell line, JAR, to determine whether triiodothyronine (T3), thyroxine (T4) and reverse T3 (rT3) are carried by the same transport mechanism. Uptake of 125I-T3, 125I-T4 and 125I-rT3 was saturable and stereospecific, but not specific for T3, T4 and rT3, as unlabelled L-stereoisomers of the thyroid hormones inhibited uptake of each of the radiolabelled hormones. Efflux of 125I-T3 was also saturable and stereospecific and was inhibited by T4 and rT3. Efflux of 125I-T4 or 125I-rT3 was, in contrast, not significantly inhibited by any of the unlabelled thyroid hormones tested. A range of compounds known to interfere with receptor-mediated thyroid hormone uptake in cells inhibited uptake of 125I-T3 and 125I-rT3, but not 125I-T4. We conclude that in JAR cells uptake and efflux of 125I-T3 are mediated by saturable and stereospecific membrane transport processes. In contrast, the uptake, but not the efflux, of 125I-T4 and 125I-rT3 is saturable and stereospecific, indicating that uptake and efflux of T4 and rT3 in JAR cells occur by different mechanisms. These results suggest that in JAR cells thyroid hormones may be transported by at least two types of transporters: a low affinity iodothyronine transporter (Michaelis constant, Km, around 1 microM) which interacts with T3, T4 and rT3, but not amino acids, and an amino acid transporter which takes up T3, but not T4 or rT3. Efflux of T4 and rT3 appears to occur by passive diffusion in these cells.


Subject(s)
Choriocarcinoma/metabolism , Thyroid Hormones/metabolism , Uterine Neoplasms/metabolism , Analysis of Variance , Biological Transport , Biological Transport, Active , Female , Humans , Iodine Radioisotopes , Thyroxine/metabolism , Triiodothyronine/metabolism , Triiodothyronine, Reverse/metabolism , Tumor Cells, Cultured
14.
Placenta ; 20(2-3): 161-5, 1999.
Article in English | MEDLINE | ID: mdl-10195736

ABSTRACT

This study investigated uptake of triiodothyronine sulphate (T3S) and interactions between uptake of T3S and triiodothyronine (T3) using the human choriocarcinoma cell line (JAr) as a model of placental transport. Cells were incubated at 37 degrees C with 30 pM 125I-T3 for 2 min with unlabelled T3 (0-30 microM) or T3S (0-1 mM). Addition of an excess unlabelled T3 (30 microM) or T3S (1 mM) reduced the initial rate of 125I-T3 uptake by 69.3+/-3.6 per cent (P<0.0001) and 52.9+/-7.8 per cent (P<0.0001), respectively. The calculated Michaelis constant (Km) for T3 uptake was 0.378+/-0.133 microM (n = 3) with a corresponding maximum velocity (Vmax) of 15.4+/-6.9 pmol/min/mg protein. Uptake of 125I-T3 was inhibited in a dose-dependent way by the addition of unlabelled T3S (0-1 mM). The calculated inhibition constant (Ki) for the inhibition of 125I-T3 uptake by T3S was 121.8+/-35.2 microM (n = 6). Saturable uptake of 125I-T3S by JAr cells was negligible. The T3S preparation incubated with the cells contained about 0.1 per cent T3, sufficient to explain the apparent inhibition of 125I-T3 uptake by unlabelled T3S. These results suggest that, in contrast to T3 uptake in these cells, JAr cells do not have a saturable uptake mechanism for T3S, and that T3S does not interact with the T3 transporter in these cells.


Subject(s)
Choriocarcinoma/metabolism , Triiodothyronine/analogs & derivatives , Uterine Neoplasms/metabolism , Biological Transport , Female , Humans , Iodine Radioisotopes , Kinetics , Placenta/metabolism , Pregnancy , Triiodothyronine/metabolism , Triiodothyronine/pharmacology , Tumor Cells, Cultured
15.
Placenta ; 20(1): 65-70, 1999 Jan.
Article in English | MEDLINE | ID: mdl-9950146

ABSTRACT

The uptake and efflux of reverse triiodothyronine (rT3) in JAr cells were investigated. Uptake of 125I-rT3 was time dependent and reversible with a saturable component of around 70 per cent of total uptake after 30 min of incubation. Efflux was not saturable. Kinetic analysis of the initial specific uptake rates revealed an uptake process with a Michaelis constant of 3.04+/-0.53 microM (mean+/-SEM, n=15) and a corresponding maximum velocity of 9.65+/-2.49 pmol/min/mg protein (n=15). Uptake of rT3 was stereospecific, but not specific for rT3, as unlabelled L stereoisomers of thyroid hormone analogues were more effective as inhibitors of 125I-rT3 uptake than rT3. Unlabelled T3 and thyroxine (T4) (10 microM) reduced cellular uptake of 125I-rT3 by around 82 and 74 per cent, respectively. The calculated inhibition constants Ki were 1.23+/-0.29 microM (n=4) and 0.66+/-0.19 microM (n=4) for T3 and T4, respectively. Similarly, rT3 reduced cellular uptake of 125I-T3 and 125I-T4 by 34 and 23 per cent, respectively. The calculated inhibition constants Ki were 1.75+/-0.55 microM (n=8) and 1.08+/-0.36 microM (n=8) for the inhibition of 125I-T3 and 125I-T4 uptake, respectively. Reverse T3 inhibited efflux of 125I-T3 from the cells by around 20 per cent, but did not inhibit efflux of 125I-T4. These results suggest that uptake of rT3 in JAr cells may occur via a single, saturable membrane carrier, which also interacts with T3 and T4, while efflux of rT3 may occur by passive diffusion.


Subject(s)
Choriocarcinoma/metabolism , Triiodothyronine, Reverse/metabolism , Uterine Neoplasms/metabolism , Female , Humans , Iodine Radioisotopes , Kinetics , Pregnancy , Thyroxine/pharmacology , Triiodothyronine/pharmacology , Tumor Cells, Cultured
16.
J Adolesc ; 21(4): 407-14, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9757405

ABSTRACT

Some type of suicidal communication precedes 80% of attempted and completed suicides in adolescents. This study investigates the relationship between the number of suicidal communications prior to an attempt and the lethality of the attempt in a sample of adolescent youth residing in a residential treatment facility. The sample consisted of 46 youth who had a suicide attempt while in a large group home residential facility over a 9-year period. Results indicated that attempters who made fewer suicidal communications beforehand tended to use more lethal methods in their attempts. Attempters with two or more preceding suicidal communications had significantly lower lethality in their attempts than did those with fewer suicidal communications. Few differences emerged between the groups in regards to demographic or psychosocial variables.


Subject(s)
Communication , Residential Treatment , Suicide Prevention , Suicide, Attempted/prevention & control , Adolescent , Female , Humans , Male , Motivation , Risk Factors , Suicide/psychology , Suicide, Attempted/psychology
17.
Nurs Forum ; 33(4): 5-11, 1998.
Article in English | MEDLINE | ID: mdl-10205484

ABSTRACT

Within the last decade there has been a multitude of research related to the phenomenon of caregiver burden. Although the concept is relatively new in the literature, the responsibility and ultimately consequences of caring for another family member has existed for centuries. Often this responsibility lies with the female members of the family, but lately more husbands, sons, close family members, or friends have assumed the primary caregiver role. This article reviews the concept of caregiver burden from a historical perspective. Research related to the definition of the concept and its impact on women, men, and siblings and the effect of ethnicity, is discussed.


Subject(s)
Attitude to Health , Caregivers/history , Cost of Illness , Family Health , Attitude to Health/ethnology , Female , Gender Identity , History, 18th Century , History, 19th Century , History, 20th Century , Humans , Male , United States
18.
Placenta ; 18(7): 535-40, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9290148

ABSTRACT

The effects of cell swelling induced by hyposmotic shock on efflux of hybrid hormones and selected amino acids from human placental tissue were examined. Decreasing the osmolarity of external medium from 290 to 140 mOsm/kg stimulated release of taurine, tryptophan and glutamine from placental tissue fragments. The efflux rate constant for taurine increased from 0.0069 +/- 0.0012/min to 0.0646 +/- 0.0217/min (n = 6) (P < 0.001), for tryptophan from 0.016 +/- 0.0010/min to 0.0295 +/- 0.0016/min (n = 6) (P < 0.001), and for glutamine from 0.0267 +/- 0.0027/min to 0.0659 +/- 0.0043/min (n = 4) (P < 0.001). In contrast, hyposmotic challenge did not affect release of triiodothyronine, thyroxine and leucine. These results indicate that transport processes involved in the regulation of cellular volume are unlikely to facilitate efflux of thyroid hormones from placental tissue, and therefore are unlikely to mediate transfer of thyroid hormones across the placenta. In addition, it is unlikely that the transport system facilitating the release of amino acids from placental tissue during regulatory volume decrease is one of the known amino acid carriers.


Subject(s)
Placenta/cytology , Placenta/metabolism , Thyroid Hormones/metabolism , Cell Size , Female , Glutamine/metabolism , Humans , Hypotonic Solutions , Leucine/metabolism , Osmolar Concentration , Pregnancy , Taurine/metabolism , Thyroxine/metabolism , Triiodothyronine/metabolism , Tryptophan/metabolism
19.
J Endocrinol ; 146(2): 233-8, 1995 Aug.
Article in English | MEDLINE | ID: mdl-7561634

ABSTRACT

We have studied the uptake of 125I-thyroxine (125I-T4) in the human choriocarcinoma cell line JAR. Uptake of 125I-T4 was time-dependent, stereospecific and reversible, with a saturable component of 33% after 120 min of incubation. Kinetic analysis of the initial specific uptake rates indicated the presence of a single uptake process with a Michaelis constant of 59.4 +/- 13.9 nM (n = 12) and maximum velocity of 0.29 +/- 0.06 pmol/min per mg protein. Uptake was dependent on intracellular energy as, in the presence of 2 nM potassium cyanide, saturable uptake was reduced to 60.6 +/- 8.5% (n = 4) of control uptake. Uptake was also temperature-dependent. Saturable 125I-T4 uptake after 60 min of incubation was 26.1 +/- 3.0% at 25 degrees C (n = 6) and 27.3 +/- 5.7% at 4 degrees C of control uptake at 37 degrees C. Ouabain did not inhibit 125I-T4 uptake indicating that the uptake was independent of the Na+ gradient across the cell membrane. Although T4 uptake was stereospecific, as D-T4 failed to inhibit 125I-L-T4 uptake, it was not specific for T4, as tri-iodothyronine (T3) and reverse T3 also inhibited 125I-T4 uptake. We conclude that JAR cells have a saturable, stereospecific and reversible membrane transport mechanism for T4 which is dependent on intracellular energy, but independent of the Na+ gradient across the cell membrane.


Subject(s)
Choriocarcinoma/metabolism , Thyroxine/metabolism , Uterine Neoplasms/metabolism , Female , Humans , Kinetics , Ouabain/pharmacology , Temperature , Thyroxine/pharmacology , Time Factors , Triiodothyronine/pharmacology , Triiodothyronine, Reverse/pharmacology , Tumor Cells, Cultured
20.
J Psychosoc Nurs Ment Health Serv ; 33(5): 10-5, 1995 May.
Article in English | MEDLINE | ID: mdl-7636781

ABSTRACT

1. The widow of a spouse who committed suicide must cope with issues related to depression, anger, blame, guilt, and the stigma associated with suicide that makes recovery from this type of loss different for the survivors. 2. The predominant need of widows and widowers of suicide victims was to talk in an environment of acceptance and understanding, which could only be provided by other people who have had the same kind of experience. 3. There is no precise formula that exists to guide caregivers when assisting survivors of suicide victims, however suggestions include communicating with compassion; demonstrating care and concern; accepting the individual's grief; and offering and providing information.


Subject(s)
Adaptation, Psychological , Spouses/psychology , Suicide/psychology , Widowhood/psychology , Female , Grief , Humans , Male , Marriage/psychology , Nurse-Patient Relations , Psychotherapy, Group
SELECTION OF CITATIONS
SEARCH DETAIL
...